Urology Medical News about osteoprotegerin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing’s syndrome
European Journal of Endocrinology, 10/14/09

Camozzi V et al. – In CS the authors found increased OPG that remained unchanged after recovery. High OPG was also observed in microvascular damage and was associated to an increased cardiovascular mortality. Therefore, high levels of OPG could reflects the persistent damage of the GCs on cardiovascular system.

<< Previous
Reliability and normal ranges for the Patients Perception of...

Next >>
Urinary fluorescence in situ hybridization assay for detecting...

MG-63 Osteoblast-like Cells Enhance the Osteoprotegerin Expression of PC-3 Prostate Cancer Cells
Anticancer Research, 11/10/09 Relevance Score: 85%

Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites
Atherosclerosis, 10/15/09 Relevance Score: 84%

Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus
Acta Diabetologia, 10/09/09 Relevance Score: 82%

A Single-Nucleotide Polymorphism in the Gene Encoding Osteoprotegerin Is Associated With Diastolic Blood Pressure in Older Men
American Journal of Hypertension, 10/28/09 Relevance Score: 80%

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-B signal
Molecular Pharmacology, 10/19/09 Relevance Score: 80%